Search

everythinglearnresearchcommunity

for

Search:↓

The supplement did not work better than a placebo for hair loss in women over 60.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

The treatment showed promising hair growth results but needs more research.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

PRP may help treat female hair loss, but more research needed.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

HPDAlR nanoparticles greatly improve skin wound healing without toxicity.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Cyclohexyl salicylate promotes human hair growth and increases certain hair follicle stem cell progeny.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Placebo effects in alopecia treatments are likely due to study design, not real improvement.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.